| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abiraterone acetate: a hat trick of clinical benefits
|
Schweizer, Michael T
|
|
2012
|
13 |
12 |
p. 1173-1174
2 p.
|
artikel
|
| 2 |
Active Surveillance for Localized Prostate Cancer
|
Schröder, Fritz H
|
|
2012
|
13 |
12 |
p. 1200-
1 p.
|
artikel
|
| 3 |
Adjuvant bevacizumab in colon cancer: where did we go wrong?
|
Seymour, Matthew T
|
|
2012
|
13 |
12 |
p. 1176-1177
2 p.
|
artikel
|
| 4 |
Aspirin for PIK3CA-mutated colorectal cancer
|
Gilbert, Judith A
|
|
2012
|
13 |
12 |
p. e522-
1 p.
|
artikel
|
| 5 |
Betrayed by Nature
|
Gallagher, William
|
|
2012
|
13 |
12 |
p. 1198-1199
2 p.
|
artikel
|
| 6 |
Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial
|
de Gramont, Aimery
|
|
2012
|
13 |
12 |
p. 1225-1233
9 p.
|
artikel
|
| 7 |
Cancer and men who have sex with men: a systematic review
|
Boehmer, Ulrike
|
|
2012
|
13 |
12 |
p. e545-e553
nvt p.
|
artikel
|
| 8 |
Cancer of the heart
|
Corn, Benjamin W
|
|
2012
|
13 |
12 |
p. 1196-1197
2 p.
|
artikel
|
| 9 |
Carcinogenicity of trichloroethylene, tetrachloroethylene, some other chlorinated solvents, and their metabolites
|
Guha, Neela
|
|
2012
|
13 |
12 |
p. 1192-1193
2 p.
|
artikel
|
| 10 |
ChIPing away at breast cancer
|
Magnani, Luca
|
|
2012
|
13 |
12 |
p. 1185-1187
3 p.
|
artikel
|
| 11 |
Combination treatment for acute myeloid leukaemia
|
Tanday, Sanjay
|
|
2012
|
13 |
12 |
p. e524-
1 p.
|
artikel
|
| 12 |
Comparative outcomes of rectal cancer surgery between elderly and non-elderly patients: a systematic review
|
Manceau, Gilles
|
|
2012
|
13 |
12 |
p. e525-e536
nvt p.
|
artikel
|
| 13 |
Conventional chemotherapy (CHOEP-14) with rituximab or high-dose chemotherapy (MegaCHOEP) with rituximab for young, high-risk patients with aggressive B-cell lymphoma: an open-label, randomised, phase 3 trial (DSHNHL 2002-1)
|
Schmitz, Norbert
|
|
2012
|
13 |
12 |
p. 1250-1259
10 p.
|
artikel
|
| 14 |
Correction to Lancet Oncol 2012; 13: 1076–78
|
|
|
2012
|
13 |
12 |
p. e520-
1 p.
|
artikel
|
| 15 |
Correction to Lancet Oncol 2012; 13: 1065
|
|
|
2012
|
13 |
12 |
p. e520-
1 p.
|
artikel
|
| 16 |
Decision making in non-AIDS-defining malignancies
|
Aboulafia, David M
|
|
2012
|
13 |
12 |
p. 1172-1173
2 p.
|
artikel
|
| 17 |
Detecting Lynch syndrome in patients with colorectal cancer
|
Gilbert, Judith A
|
|
2012
|
13 |
12 |
p. e521-
1 p.
|
artikel
|
| 18 |
Dying To Be Me
|
Chee, Hooi Ping
|
|
2012
|
13 |
12 |
p. 1201-
1 p.
|
artikel
|
| 19 |
Effect of abiraterone acetate and prednisone compared with placebo and prednisone on pain control and skeletal-related events in patients with metastatic castration-resistant prostate cancer: exploratory analysis of data from the COU-AA-301 randomised trial
|
Logothetis, Christopher J
|
|
2012
|
13 |
12 |
p. 1210-1217
8 p.
|
artikel
|
| 20 |
Effect of HIV on survival in patients with non-small-cell lung cancer in the era of highly active antiretroviral therapy: a population-based study
|
Rengan, Ramesh
|
|
2012
|
13 |
12 |
p. 1203-1209
7 p.
|
artikel
|
| 21 |
Full Body Burden
|
Human, Katy
|
|
2012
|
13 |
12 |
p. 1199-1200
2 p.
|
artikel
|
| 22 |
Genetic and epigenetic factors in development of lung cancer
|
Marshall, Hilary
|
|
2012
|
13 |
12 |
p. 1188-
1 p.
|
artikel
|
| 23 |
Harms versus benefits with duration of androgen suppression
|
Nguyen, Paul L
|
|
2012
|
13 |
12 |
p. 1182-1183
2 p.
|
artikel
|
| 24 |
IGF-1 and BRCA1 signalling pathways in familial cancer
|
Werner, Haim
|
|
2012
|
13 |
12 |
p. e537-e544
nvt p.
|
artikel
|
| 25 |
Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial
|
Robertson, Kent A
|
|
2012
|
13 |
12 |
p. 1218-1224
7 p.
|
artikel
|
| 26 |
Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial
|
Mathers, John C
|
|
2012
|
13 |
12 |
p. 1242-1249
8 p.
|
artikel
|
| 27 |
Medical screening: prevention can be bad for your health
|
Ioannidis, John PA
|
|
2012
|
13 |
12 |
p. 1201-1202
2 p.
|
artikel
|
| 28 |
NICE guidance on denosumab for prevention of skeletal-related events in adults with bone metastases from solid tumours
|
Jilani, Anwar
|
|
2012
|
13 |
12 |
p. 1194-1195
2 p.
|
artikel
|
| 29 |
Novel diagnostic modalities for assessment of the clinically node-negative neck in oral squamous-cell carcinoma
|
Leusink, Frank KJ
|
|
2012
|
13 |
12 |
p. e554-e561
nvt p.
|
artikel
|
| 30 |
Obama: health-care reform, part two
|
The Lancet Oncology,
|
|
2012
|
13 |
12 |
p. 1171-
1 p.
|
artikel
|
| 31 |
Patients' expectations of chemotherapy
|
Burki, Talha Khan
|
|
2012
|
13 |
12 |
p. e523-
1 p.
|
artikel
|
| 32 |
Peripheral-blood stem cells or bone marrow for leukaemia?
|
Benmaamar, Ramla
|
|
2012
|
13 |
12 |
p. e521-
1 p.
|
artikel
|
| 33 |
Positive results for ibrutinib in B-cell malignancies
|
Senior, Kathryn
|
|
2012
|
13 |
12 |
p. e522-
1 p.
|
artikel
|
| 34 |
Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial
|
Denham, James W
|
|
2012
|
13 |
12 |
p. 1260-1270
11 p.
|
artikel
|
| 35 |
Radiation oncology escapes drastic cuts to Medicare fees
|
Cagney, Hannah
|
|
2012
|
13 |
12 |
p. e523-
1 p.
|
artikel
|
| 36 |
Role of the investigator in phase 1 trials of anticancer drugs
|
Penel, Nicolas
|
|
2012
|
13 |
12 |
p. 1177-1179
3 p.
|
artikel
|
| 37 |
Stand Up To Cancer
|
Burki, Talha Khan
|
|
2012
|
13 |
12 |
p. 1197-1198
2 p.
|
artikel
|
| 38 |
Statin use associated with reduced cancer-related mortality
|
Cagney, Hannah
|
|
2012
|
13 |
12 |
p. e524-
1 p.
|
artikel
|
| 39 |
Taking the starch out of hereditary colorectal cancer
|
Boland, C Richard
|
|
2012
|
13 |
12 |
p. 1179-1180
2 p.
|
artikel
|
| 40 |
TAS-102: more than an antimetabolite
|
Peters, Godefridus J
|
|
2012
|
13 |
12 |
p. e518-e519
nvt p.
|
artikel
|
| 41 |
24th AACR-NCI-EORTC Symposium
|
Smith, Lan-Lan
|
|
2012
|
13 |
12 |
p. 1191-
1 p.
|
artikel
|
| 42 |
54th ASTRO annual meeting
|
Heald, Rebecca
|
|
2012
|
13 |
12 |
p. 1189-
1 p.
|
artikel
|
| 43 |
The evolution of radioembolisation
|
Smits, Maarten LJ
|
|
2012
|
13 |
12 |
p. e519-
1 p.
|
artikel
|
| 44 |
8th NCRI Cancer Conference
|
Sansom, Clare
|
|
2012
|
13 |
12 |
p. 1190-
1 p.
|
artikel
|
| 45 |
Time for a low-risk DCIS trial: harnessing public and patient involvement
|
Fallowfield, Lesley
|
|
2012
|
13 |
12 |
p. 1183-1185
3 p.
|
artikel
|
| 46 |
Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study
|
Mamot, Christoph
|
|
2012
|
13 |
12 |
p. 1234-1241
8 p.
|
artikel
|
| 47 |
Treatment for plexiform neurofibromas in patients with NF1
|
Ardern-Holmes, Simone L
|
|
2012
|
13 |
12 |
p. 1175-1176
2 p.
|
artikel
|
| 48 |
Voices from the front: December
|
Mastrianni, David M
|
|
2012
|
13 |
12 |
p. 1202-
1 p.
|
artikel
|
| 49 |
Which treatment for high-risk patients with DLBCL?
|
Coiffier, Bertrand
|
|
2012
|
13 |
12 |
p. 1180-1182
3 p.
|
artikel
|
Tijdschrift beschrijving